Xin Jin

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 30

Top Venues

Cell death & disease

Cancer research

Journal of experimental & clinical cancer research : CR

Oncogene

Huazhong University of Science and Technology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Huazhong University of Science and Technology Sep 1o 2005 - Jun 30o 2013

China

PHD :: tongji medical college

Publications

Zhenlin Huang, Xiang Li, Bo Tang, Hao Li, Jianong Zhang, Rui Sun, Jian Ma, Yunqian Pan, Binyuan Yan, Yingke Zhou, Dongling Ding, Yuqian Yan, Raphael E Jimenez, Jacob J Orme, Xin Jin, Jinjian Yang, Zhenlin Huang, Zhankui Jia
SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer research 83 (6) (2023)
Chong Yang, Xin Jin, Xingchao Liu, Gang Wu, Wenhao Yang, Beichuan Pang, Jipeng Jiang, Dongxu Liao, Yu Zhang
TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs. Cell death & disease 14 (1) (2023)
Huaiyuan Liang, Chunguang Yang, Ruijiang Zeng, Yingqiu Song, Jianxi Wang, Wei Xiong, Binyuan Yan, Xin Jin
Targeting CBX3 with a Dual BET/PLK1 Inhibitor Enhances the Antitumor Efficacy of CDK4/6 Inhibitors in Prostate Cancer. Advanced science (Weinheim, Baden-Wurttemberg, Germany) (2023)
Chong Yang, Xin Jin, Xingchao Liu, Gang Wu, Wenhao Yang, Beichuan Pang, Jipeng Jiang, Dongxu Liao, Yu Zhang
TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs. Cell death & disease 14 (1) (2023)
Zhenlin Huang, Xiang Li, Bo Tang, Hao Li, Jianong Zhang, Rui Sun, Jian Ma, Yunqian Pan, Binyuan Yan, Yingke Zhou, Dongling Ding, Yuqian Yan, Raphael E Jimenez, Jacob J Orme, Xin Jin, Jinjian Yang, Zhenlin Huang, Zhankui Jia
SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer research 83 (6) (2023)
Yapeng Wang, Mou Peng, Yawen Zhong, Wei Xiong, Liang Zhu, Xin Jin
The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis. Oncogene (2023)
Chong Yang, Xin Jin, Xingchao Liu, Gang Wu, Wenhao Yang, Beichuan Pang, Jipeng Jiang, Dongxu Liao, Yu Zhang
TRIM15 forms a regulatory loop with the AKT/FOXO1 axis and LASP1 to modulate the sensitivity of HCC cells to TKIs. Cell death & disease 14 (1) (2023)
Yan Sun, Liang Zhu, Pian Liu, Huan Zhang, Feng Guo, Xin Jin
ZDHHC2-mediated AGK palmitoylation activates AKT/mTOR signaling to reduce sunitinib sensitivity in renal cell carcinoma. Cancer research (2023)
Yapeng Wang, Mou Peng, Yawen Zhong, Wei Xiong, Liang Zhu, Xin Jin
The E3 ligase RBCK1 reduces the sensitivity of ccRCC to sunitinib through the ANKRD35-MITD1-ANXA1 axis. Oncogene 42 (13) (2023)
Bin Yan, Xurui Li, Mou Peng, Yali Zuo, Yinhuai Wang, Pian Liu, Weigang Ren, Xin Jin
The YTHDC1/GLUT3/RNF183 axis forms a positive feedback loop that modulates glucose metabolism and bladder cancer progression. Experimental & molecular medicine (2023)
Yan Sun, Xin Jin, Junpeng Meng, Feng Guo, Taoyu Chen, Xiaoyan Zhao, Heshui Wu, Dianyun Ren
MST2 methylation by PRMT5 inhibits Hippo signaling and promotes pancreatic cancer progression. The EMBO journal (2023)
Zhenlin Huang, Xiang Li, Bo Tang, Hao Li, Jianong Zhang, Rui Sun, Jian Ma, Yunqian Pan, Binyuan Yan, Yingke Zhou, Dongling Ding, Yuqian Yan, Raphael E Jimenez, Jacob J Orme, Xin Jin, Jinjian Yang, Zhenlin Huang, Zhankui Jia
SETDB1 modulates degradation of phosphorylated RB and anti-cancer efficacy of CDK4/6 inhibitors. Cancer research (2023)
Wentao Liu, Bin Zhang, Dan Zhang, Feng Guo, Kun Ye, Liang Zhu, Xin Jin
The RBPJ/DAPK3/UBE3A signaling axis induces PBRM1 degradation to modulate the sensitivity of renal cell carcinoma to CDK4/6 inhibitors. Cell death & disease 13 (4) (2022)
Dan Zhang, Jing Tang, Yunhong Xu, Xiaoju Huang, Yilin Wang, Xin Jin, Gang Wu, Pian Liu
Global crotonylome reveals hypoxia-mediated lamin A crotonylation regulated by HDAC6 in liver cancer. Cell death & disease 13 (8) (2022)
Feng Guo, Xiang Cheng, Boping Jing, Heshui Wu, Xin Jin
FGD3 binds with HSF4 to suppress p65 expression and inhibit pancreatic cancer progression. Oncogene 41 (6) (2022)
Jiannan Ren, Haixin Yu, Wei Li, Xin Jin, Bin Yan
Downregulation of CBX7 induced by EZH2 upregulates FGFR3 expression to reduce sensitivity to cisplatin in bladder cancer. British journal of cancer (2022)
Wentao Liu, Dianyun Ren, Wei Xiong, Xin Jin, Liang Zhu
A novel FBW7/NFAT1 axis regulates cancer immunity in sunitinib-resistant renal cancer by inducing PD-L1 expression. Journal of experimental & clinical cancer research : CR 41 (1) (2022)
Feng Guo, Yingke Zhou, Hui Guo, Dianyun Ren, Xin Jin, Heshui Wu
NR5A2 transcriptional activation by BRD4 promotes pancreatic cancer progression by upregulating GDF15. Cell death discovery 7 (1) (2021)
Bin Zhang, Xiang Cheng, Sudong Zhan, Xin Jin, Tao Liu
MIB1 upregulates IQGAP1 and promotes pancreatic cancer progression by inducing ST7 degradation. Molecular oncology 15 (11) (2021)
Lu Yi, Haohui Wang, Wei Li, Kun Ye, Wei Xiong, Haixin Yu, Xin Jin
The FOXM1/RNF26/p57 axis regulates the cell cycle to promote the aggressiveness of bladder cancer. Cell death & disease 12 (10) (2021)
Yongjun Wang, Dong Han, Tingwen Zhou, Cheng Chen, Hong Cao, Joe Z Zhang, Ning Ma, Chun Liu, Moshi Song, Jiawei Shi, Xin Jin, Feng Cao, Nianguo Dong
DUSP26 induces aortic valve calcification by antagonizing MDM2-mediated ubiquitination of DPP4 in human valvular interstitial cells. European heart journal 42 (30) (2021)
Yan Sun, Dianyun Ren, Yingke Zhou, Jian Shen, Heshui Wu, Xin Jin
Histone acetyltransferase 1 promotes gemcitabine resistance by regulating the PVT1/EZH2 complex in pancreatic cancer. Cell death & disease 12 (10) (2021)
Mi Li, Wei Wu, Sisi Deng, Zengwu Shao, Xin Jin
TRAIP modulates the IGFBP3/AKT pathway to enhance the invasion and proliferation of osteosarcoma by promoting KANK1 degradation. Cell death & disease 12 (8) (2021)
Wei Xiong, Bin Zhang, Haixin Yu, Liang Zhu, Lu Yi, Xin Jin
RRM2 Regulates Sensitivity to Sunitinib and PD-1 Blockade in Renal Cancer by Stabilizing ANXA1 and Activating the AKT Pathway. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (18) (2021)
Dianyun Ren, Yan Sun, Dan Li, Heshui Wu, Xin Jin
USP22-mediated deubiquitination of PTEN inhibits pancreatic cancer progression by inducing p21 expression. Molecular oncology (2021)
Yingke Zhou, Xin Jin, Jian Ma, Donglin Ding, Zhenlin Huang, Haoyue Sheng, Yuqian Yan, Yunqian Pan, Ting Wei, Liguo Wang, Heshui Wu
HDAC5 Loss Impairs RB Repression of Pro-Oncogenic Genes and Confers CDK4/6 Inhibitor Resistance in Cancer. Cancer research 81 (6) (2021)
Juan Li, Can Jin, Chuanxin Zou, Xu Qiao, Peng Ma, Di Hu, Wenqin Li, Jun Jin, Xin Jin, Ping Fan
GNG12 regulates PD-L1 expression by activating NF-κB signaling in pancreatic ductal adenocarcinoma. FEBS open bio 10 (2) (2020)
Dianyun Ren, Jingyuan Zhao, Yan Sun, Dan Li, Zibo Meng, Bo Wang, Ping Fan, Zhiqiang Liu, Xin Jin, Heshui Wu
Overexpressed ITGA2 promotes malignant tumor aggression by up-regulating PD-L1 expression through the activation of the STAT3 signaling pathway. Journal of experimental & clinical cancer research : CR 38 (1) (2019)
Rui Fang, Bin Zhang, Xiaoming Lu, Xin Jin, Tao Liu
FASTKD2 promotes cancer cell progression through upregulating Myc expression in pancreatic ductal adenocarcinoma. Journal of cellular biochemistry 121 (3) (2019)
Xin Jin, Rui Fang, Ping Fan, Lipeng Zeng, Bin Zhang, Xiaoming Lu, Tao Liu
PES1 promotes BET inhibitors resistance and cells proliferation through increasing c-Myc expression in pancreatic cancer. Journal of experimental & clinical cancer research : CR 38 (1) (2019)

Xin Jin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xin Jin